Pharma Industry News Weekly Recap: September 8, 2023

2023-09-08T06:22:36-07:004IR, AI, Biden, Cancer, Cardiovascular, COVID-19, Diabetes, Digital Health, Digital Innovation, Drug Discovery, Drug Pricing, FDA, Industry News, Machine Learning, Medical Marijuana, Obesity, Opioids, Politics, Research, Vaccines|

// Biotech and Pharma Therapeutics Bicycle Health, Albertsons partner to boost access to opioid use disorder injections September 5, [...]

Pharma Industry News Weekly Recap: September 1, 2023

2023-09-01T06:55:02-07:004IR, AI, Biden, Cancer, Cardiovascular, COVID-19, Diabetes, Digital Health, Digital Innovation, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Machine Learning, Medical Marijuana, Obesity, Opioids, Politics, Private Equity & Venture Capital, Regulatory, Research, Vaccines|

// Biotech and Pharma Therapeutics BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, [...]

Pharma Industry News Weekly Recap: August 4, 2023

2023-08-04T06:10:57-07:004IR, AI, Diabetes, Digital Health, Digital Innovation, Drug Discovery, Drug Pricing, FDA, Industry News, Machine Learning, Oncology, Politics, Regulatory, Research, Vaccines, Wearables|

// Biotech and Pharma Therapeutics ProQR draws line under its eye disease era, offloading 2 assets to Théa [...]

Pharma Industry News Weekly Recap: July 14, 2023

2023-07-14T07:42:19-07:004IR, AI, Diabetes, Digital Health, Digital Innovation, Drug Discovery, Drug Pricing, FDA, Industry News, Machine Learning, Oncology, Politics, Regulatory, Research, Vaccines, Wearables|

// Biotech and Pharma Therapeutics Expanding Access to Women’s Health Fresenius Kabi Launches Generic Fertility Treatment July 10, [...]

Pharma Industry News Weekly Recap: July 7, 2023

2023-07-07T06:57:51-07:004IR, AI, Diabetes, Digital Health, Digital Innovation, Drug Discovery, Drug Pricing, FDA, Industry News, Machine Learning, Oncology, Politics, Regulatory, Research, Vaccines, Wearables|

// Biotech and Pharma Therapeutics AbbVie sends SHP2 deal back to port, following Big Pharma peer in retreating [...]

Go to Top